Comera Life Sciences Holdings, Inc. (CMRA)

USD 0.0

(0.0%)

Market Cap (In USD)

6148.00

Revenue (In USD)

633.1 Thousand

Net Income (In USD)

-18.37 Million

Avg. Volume

788.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-4-0.09
PE
-
EPS
-0.22
Beta Value
-20.429
ISIN
US20037C1080
CUSIP
20037C108
CIK
1907685
Shares
30737800.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Michael G. Campbell CPA
Employee Count
-
Website
https://comeralifesciences.com
Ipo Date
2020-12-21
Details
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.